Linked Life Data

3075836

Source:http://linkedlifedata.com/resource/pubmed/id/3075836

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1989-8-14
pubmed:abstractText
A total of 42 patients (22 previously untreated and 20 previously treated) with GH deficiency were included in a Spanish multicentre trial of recombinant somatropin, 0.5 IU/kg/week. In previously untreated patients typical catch-up growth was observed and the height velocity increased from 3.3 +/- 0.6 cm/year to 9.8 +/- 2.4 cm/year during 1 year of therapy. In previously treated children, the height velocity was maintained (7.2 +/- 2.0 cm/year at the start and 7.9 +/- 1.6 cm/year after 1 year). No anti-GH antibodies were detected in previously untreated patients, and they disappeared from previously treated ones. No adverse reactions were reported.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0300-8843
pubmed:author
pubmed:issnType
Print
pubmed:volume
347
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
180-3
pubmed:dateRevised
2008-2-20
pubmed:meshHeading
pubmed:year
1988
pubmed:articleTitle
Spanish multicentre trial of recombinant somatropin. Spanish Collaborative Group.
pubmed:affiliation
Endocrinology Unit, Children's Hospital Vall d'Hebron, Barcelona, Spain.
pubmed:publicationType
Journal Article, Clinical Trial, Multicenter Study